T2 Biosystems, Inc. (TTOO)

USD 0.35

(2.88%)

Inventory Summary of T2 Biosystems, Inc.

  • T2 Biosystems, Inc.'s latest annual inventory in 2023 was 4.81 Million USD , up 10.81% from previous year.
  • T2 Biosystems, Inc.'s latest quarterly inventory in 2024 Q2 was 5.16 Million USD , up 10.69% from previous quarter.
  • T2 Biosystems, Inc. reported annual inventory of 4.34 Million USD in 2022, up 11.26% from previous year.
  • T2 Biosystems, Inc. reported annual inventory of 3.9 Million USD in 2021, up 7.51% from previous year.
  • T2 Biosystems, Inc. reported quarterly inventory of 4.67 Million USD for 2024 Q1, down -3.09% from previous quarter.
  • T2 Biosystems, Inc. reported quarterly inventory of 4.81 Million USD for 2023 Q4, up 12.57% from previous quarter.

Annual Inventory Chart of T2 Biosystems, Inc. (2023 - 2012)

Historical Annual Inventory of T2 Biosystems, Inc. (2023 - 2012)

Year Inventory Inventory Growth
2023 4.81 Million USD 10.81%
2022 4.34 Million USD 11.26%
2021 3.9 Million USD 7.51%
2020 3.63 Million USD 1.03%
2019 3.59 Million USD 34.44%
2018 2.67 Million USD 99.18%
2017 1.34 Million USD 67.37%
2016 803 Thousand USD 17.57%
2015 683 Thousand USD 493.91%
2014 115 Thousand USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Inventory Comparison of T2 Biosystems, Inc.

Name Inventory Inventory Difference
Bionano Genomics, Inc. 22.89 Million USD 78.95%
Prenetics Global Limited 3.12 Million USD -54.12%
Star Equity Holdings, Inc. 3.42 Million USD -40.906%
CareDx, Inc 19.47 Million USD 75.25%
Exact Sciences Corporation 127.47 Million USD 96.22%
Exagen Inc. 2.87 Million USD -67.851%
Inotiv, Inc. 56.1 Million USD 91.41%
Guardant Health, Inc. 61.94 Million USD 92.221%
Biodesix, Inc. 1.4 Million USD -244.214%
BioNexus Gene Lab Corp. 1.13 Million USD -323.548%
Precipio, Inc. 384 Thousand USD -1154.948%
iSpecimen Inc. - USD -Infinity%
Natera, Inc. 40.75 Million USD 88.177%
Aspira Women's Health Inc. 227 Thousand USD -2022.907%
Standard BioTools Inc. 20.53 Million USD 76.53%
23andMe Holding Co. 12.46 Million USD 61.34%
Castle Biosciences, Inc. 7.94 Million USD 39.323%
Personalis, Inc. 5.66 Million USD 14.874%
Aclaris Therapeutics, Inc. - USD -Infinity%
Applied DNA Sciences, Inc. 330.02 Thousand USD -1360.184%
OpGen, Inc. 1.00 USD -481899900.0%
Myriad Genetics, Inc. 20.1 Million USD 76.025%
ICON Public Limited Company 1.00 USD -481899900.0%
NeoGenomics, Inc. 24.15 Million USD 80.051%
Star Equity Holdings, Inc. 3.42 Million USD -40.906%
IDEXX Laboratories, Inc. 380.28 Million USD 98.733%
RadNet, Inc. 1.00 USD -481899900.0%
MDxHealth SA 2.77 Million USD -73.408%
Psychemedics Corporation 1.00 USD -481899900.0%
Illumina, Inc. 587 Million USD 99.179%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 32.06 Million USD 84.97%
DarioHealth Corp. 5.06 Million USD 4.8%
Fulgent Genetics, Inc. 5.82 Million USD 17.299%
Sera Prognostics, Inc. - USD -Infinity%
ENDRA Life Sciences Inc. 2.62 Million USD -83.73%
OPKO Health, Inc. 65.69 Million USD 92.665%
Medpace Holdings, Inc. 1.00 USD -481899900.0%
Neogen Corporation 189.26 Million USD 97.454%
Intelligent Bio Solutions Inc. 777.53 Thousand USD -519.778%
Prenetics Global Limited 3.12 Million USD -54.12%
Mainz Biomed B.V. 613.63 Thousand USD -685.316%
bioAffinity Technologies, Inc. 18.48 Thousand USD -25971.197%
Trinity Biotech plc 19.93 Million USD 75.824%
Neuronetics, Inc. 8.09 Million USD 40.455%
Sotera Health Company 51.98 Million USD 90.73%
bioAffinity Technologies, Inc. 18.48 Thousand USD -25971.197%